Priority Date: 24.10.11 (US 201161550619P)

BISPECIFIC IMMUNOBINDERS DIRECTED AGAINST TNF AND IL-17

  • Application ID: EP12783474
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1998
Headquarter in Sint-Martens-Latem and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). De Clercq & Partners cvba is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 226 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 24.10.2011 - Priority Date (US 201161550619P)
  • 02.05.2013 - Publication A1 (WO2013063110)
  • 03.09.2014 - Publication A1 (EP2771361)

IPC Classification